Indeed, according to Li et al. (2017) and Zhou et al. (2019) studies, the expression level of METTL3 with high copy number variations showed large heterogeneity in different ccRCC cohorts. This evidence concerns the gene METTL3 and nonpapillary renal cell carcinoma.